Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 94 publications
Risk-Based vs Annual Breast Cancer Screening: The WISDOM Randomized Clinical Trial.
Journal: JAMA
Published: December 12, 2025
Germline Pathogenic Variants Among Women Without a History of Breast Cancer: A Secondary Analysis of the WISDOM Randomized Clinical Trial.
Journal: JAMA internal medicine
Published: December 12, 2025
WISDOM Randomized Trial Comparing Risk-Based Versus Annual Breast Cancer Screening: Study Cohort Characteristics and Design.
Journal: Research square
Published: November 19, 2025
WISDOM randomized trial comparing risk-based versus annual breast cancer screening: study cohort characteristics and design.
Journal: NPJ breast cancer
Published: September 20, 2025
Relationship of physical activity and cognitive functioning among breast cancer survivors: a cross-sectional analysis.
Journal: Frontiers in cognition
Published: November 01, 2024
Correction: a phase 1b study of zilovertamab in combination with paclitaxel for locally advanced/unresectable or metastatic HER2-negative breast cancer.
Journal: Breast cancer research : BCR
Published: March 14, 2024
Corrigendum: Preventing sleep disruption with bright light therapy during chemotherapy for breast cancer: a phase II randomized controlled trial.
Journal: Frontiers in neuroscience
Published: February 15, 2024
A phase 1b study of zilovertamab in combination with paclitaxel for locally advanced/unresectable or metastatic Her2-negative breast cancer.
Journal: Breast cancer research : BCR
Published: October 27, 2023
Early Ascertainment of Breast Cancer Diagnoses Comparing Self-Reported Questionnaires and Electronic Health Record Data Warehouse: The WISDOM Study.
Journal: JCO clinical cancer informatics
Published: August 22, 2023
Growth signaling autonomy in circulating tumor cells aids metastatic seeding.
Journal: PNAS nexus
Published: June 20, 2023
Association of baseline ROR1 and ROR2 gene expression with clinical outcomes in the I-SPY2 neoadjuvant breast cancer trial.
Journal: Breast cancer research and treatment
Published: September 20, 2022
Last Updated: 09/26/2026